NFATC3 and nasopharyngeal carcinoma: Our study demonstrates for the first time that TRPV4 promotes NPC cell growth via the Ca2+/calcineurin/NFAT4 axis, and highlights the therapeutic potential of targeting the TRPV4/Ca2+/calcineurin/NFAT4 signaling pathway.